Molecular Predictors and Prognostic Markers in the Adjuvant Therapy for Colon Cancer

摘要: Colorectal cancer is a leading cause of cancer-related mortality in the USA. Although recent years have brought significant advances treatment metastatic setting, last major advance adjuvant setting was addition oxaliplatin to fluorouracil and leucovorin stage III disease. The benefit therapy patients with II disease not as clear. Prognostic predictive markers help stratify patient risk thereby indentify who may from therapy. goal this review define prognostic molecular predictors that should be considered when attempting personalize